Skip to main content

Applera Board Authorizes Additional Applied Biosystems Stock Buyback

NEW YORK, April 5 (GenomeWeb News) - Applera has authorized the repurchase of up to $100 million of its Applied Biosystems group's common stock, ABI said today.

 

The repurchase, approved by Applera's board of directors, has no time restrictions. Applera already repurchased $200 million, or 8.9 million shares, of Applied Biosystems' stock during fiscal year 2004.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.